Related Experiment Videos
Mianserin-induced restless legs syndrome
1Department of Neuropsychiatry, Kangnam Kangnam St Mary's Hospital, Catholic University Medical College, Seoul, Korea.
The British Journal of Psychiatry : the Journal of Mental Science
|September 1, 1989
Summary
Restless legs syndrome (RLS) emerged in three patients treated with mianserin. Reducing or stopping mianserin alleviated these RLS symptoms, indicating a potential drug-induced effect.
Area of Science:
- Pharmacology
- Neurology
- Clinical Medicine
Background:
- Mianserin is a tetracyclic antidepressant.
- Antidepressants are known to sometimes cause neurological side effects.
- Restless legs syndrome is a neurological disorder characterized by an urge to move the legs.
Observation:
- Three patients undergoing treatment with mianserin developed symptoms consistent with restless legs syndrome.
- The onset of symptoms appeared to correlate with mianserin administration.
Findings:
- A direct association between mianserin use and the development of restless legs syndrome was observed.
- The symptoms of restless legs syndrome in these patients were reversible upon dose reduction or cessation of mianserin therapy.
Implications:
- Clinicians should be aware of the potential for mianserin to induce or exacerbate restless legs syndrome.
- Further investigation into the mechanism of mianserin-induced restless legs syndrome is warranted.
- This finding may inform prescribing practices for mianserin, particularly in patients with a predisposition to restless legs syndrome.